Pearl River Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Pearl River Capital's GILD Position: Q2 2024 in Review
Pearl River Capital sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 49,375 shares — an estimated $3.62M sold.
Pearl River Capital first reported a position in GILD in Q4 2018 and held it in 13 quarters. The position peaked at $5.6M in Q3 2023. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- Pearl River Capital reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- Pearl River Capital sold 49,375 Gilead Sciences shares in Q2 2024, an estimated $3.62M.
- Pearl River Capital first reported a position in Gilead Sciences in Q4 2018 and held it in 13 quarters.
- Pearl River Capital's Gilead Sciences position peaked at $5.6M in Q3 2023.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on Pearl River Capital's 13F filing for Q2 2024, filed 13 Aug 2024.